BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11369384)

  • 1. A study of familial occurrence of Behçet's disease with and without ocular lesions.
    Nishiyama M; Nakae K; Umehara T
    Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Behçet's disease.
    Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
    Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
    Arber N; Klein T; Meiner Z; Pras E; Weinberger A
    Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease in Western Switzerland: epidemiology and analysis of ocular involvement.
    Ambresin A; Tran T; Spertini F; Herbort C
    Ocul Immunol Inflamm; 2002 Mar; 10(1):53-63. PubMed ID: 12461704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease.
    Krause L; Köhler AK; Altenburg A; Papoutsis N; Zouboulis CC; Pleyer U; Stroux A; Foerster MH
    Eye (Lond); 2009 May; 23(5):1182-6. PubMed ID: 18551141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
    Mizuki Y; Horita N; Horie Y; Takeuchi M; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Kurosawa M; Kitaichi N; Takeno M; Kaneko T; Mizuki N
    Mod Rheumatol; 2020 Jul; 30(4):708-714. PubMed ID: 31386589
    [No Abstract]   [Full Text] [Related]  

  • 7. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
    Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
    Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
    Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
    Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.
    Houman MH; Neffati H; Braham A; Harzallah O; Khanfir M; Miled M; Hamzaoui K
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S58-64. PubMed ID: 17949553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease in patients of west African and Afro-Caribbean origin.
    Poon W; Verity DH; Larkin GL; Graham EM; Stanford MR
    Br J Ophthalmol; 2003 Jul; 87(7):876-8. PubMed ID: 12812890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
    Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
    Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
    Ishido T; Horita N; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Ishigatsubo Y; Takeno M; Kurosawa M; Kaneko T; Mizuki N
    Rheumatology (Oxford); 2017 Nov; 56(11):1918-1927. PubMed ID: 28968732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behçet's disease: the first Mongolian case in literature showing HLA B51, MICA gene type *5/*6.
    Chung YL; Bang DS; Lee ES; Lee SN; Mok JW; Park KS
    Yonsei Med J; 2003 Oct; 44(5):935-8. PubMed ID: 14584116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic comparison of Behçet's disease with or without HLA-Bw 51 antigen.
    Kim MS; Kim JH
    Korean J Ophthalmol; 1989 Dec; 3(2):85-9. PubMed ID: 2635747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey.
    Seyahi E; Tahir Turanli E; Mangan MS; Celikyapi G; Oktay V; Cevirgen D; Kuzuoglu D; Ozoglu S; Yazici H
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S67-75. PubMed ID: 20868574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
    Cohen R; Metzger S; Nahir M; Chajek-Shaul T
    Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Kilmartin DJ; Finch A; Acheson RW
    Br J Ophthalmol; 1997 Aug; 81(8):649-53. PubMed ID: 9349151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-C genotyping of patient with Behçet's disease in the Japanese population.
    Mizuki N; Ohno S; Ando H; Kimura M; Ishihara M; Miyata S; Nakamura S; Mizuki N; Inoko H
    Hum Immunol; 1996 Sep; 50(1):47-53. PubMed ID: 8872174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
    Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
    Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.